JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway

Publisher: Spandidos Publications

E-ISSN: 1791-2431|33|1|494-502

ISSN: 1021-335X

Source: Oncology Reports, Vol.33, Iss.1, 2015-01, pp. : 494-502

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract